Biotech / Related Ideas

[SuperSquirrel]

Mesoblast Limited - Another new 52 week high!!! Australian Biotech with adult stem cell patents. Check it out and thank me later...

Mesoblast Limited (Mesoblast) is a biotechnology company committed to the development of adult stem cell products targeting a range of bone, cartilage and musculoskeletal conditions. The Company holds a 38.4% interest in Angioblast Systems, Inc. (Angioblast), a company developing the same platform technology for the treatment of cardiovascular diseases, including repair and regeneration of blood vessels and heart muscle. Mesoblast is developing an allogeneic or off-the-shelf cell product, called NeoFuse, to generate bony spinal fusion. In August 2009, the United States Food and Drug Administration cleared a Phase II clinical trial of its allogeneic adult stem cells for use in minimally invasive lumbar spinal fusion surgery. The 24-patient trial, based at multiple United States sites, is comparing the effectiveness and safety of two low doses, NeoFuse with autograft in minimally invasive surgery for fusion of the lumbar spine.

http://stemcelldaily.com/index.php?s=mesoblast

They also own a minority stake in Angioblast
http://stemcelldaily.com/index.php?s=angioblast

http://www.google.com/finance?q=ASX:MSB
http://www.google.com/finance?q=PINK:MEOBF
http://www.google.com/finance?q=PINK:MBLTY